bleomycetin has been researched along with Maxillary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, QF; Zhao, FY | 1 |
| Hou, J; Huang, H; Tang, H; Wang, M; Wang, Y | 1 |
| Akimova, AIa; Kislichko, AG; Ol'shanskiĭ, VO; Rusakov, IG; Savizhkov, AM | 1 |
1 trial(s) available for bleomycetin and Maxillary Neoplasms
| Article | Year |
|---|---|
[Use of cytostatics in polymer-drug complexes in the treatment of malignant neoplasms of the maxilla].
Topics: Adult; Aged; Animals; Bleomycin; Carubicin; Clinical Trials as Topic; Cyanoacrylates; Daunorubicin; Drug Evaluation, Preclinical; Drug Implants; Female; Humans; Male; Maxilla; Maxillary Neoplasms; Middle Aged; Postoperative Care; Rats | 1990 |
2 other study(ies) available for bleomycetin and Maxillary Neoplasms
| Article | Year |
|---|---|
The effects of Bleomycin A5 on infantile maxillofacial haemangioma.
Topics: Antibiotics, Antineoplastic; Bleomycin; Dose-Response Relationship, Drug; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Infant, Newborn; Injections, Intralesional; Magnetic Resonance Imaging; Male; Maxillary Neoplasms; Retrospective Studies; Treatment Outcome | 2011 |
Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients.
Topics: Antibiotics, Antineoplastic; Bleomycin; Dose-Response Relationship, Drug; Facial Neoplasms; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Injections, Intralesional; Male; Maxillary Neoplasms; Mouth Neoplasms; Sclerosing Solutions; Sclerotherapy; Treatment Outcome | 2011 |